Joice Mara de Oliveira1,2, Alcindo Cerci Neto3, Fatima Mitsie Chibana Soares3, Fabio Pitta2, Karina Couto Furlanetto1,2
Oliveira1 JM, 2 , Neto3 AC, Soares3 FMC, Pitta2 F, Furlanetto1 KC, et al. Adults with asthma treated with add-on omalizumab report less limitation in activities of daily living. J Bras Pneumol. 2022;48(1):e20210321